Viracta Therapeutics, Inc.
VIRXDelisted Jul 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001061027
Viracta Therapeutics, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Nov 27, 2024; 32 institutions reported holding it in 13F filings for Q4 2024, worth $583.0K in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Viracta Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 63 | 59 | −4 |
| Shares | 11.4M | 12.4M | +954.4K (+8.4%) |
| Value | $44.2M | $52.8M | +$8.52M (+19.3%) |
New holders (4)
Institutions that held Viracta Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rubric Capital Management LP | 994,801 | $4.25M | 0.21% |
| Dimensional Fund Advisors LP | 146,331 | $625.0K | 0.00% |
| Charles Schwab Investment Management Inc | 12,430 | $54.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 352 | $2.00K | 0.00% |
Sold out (8)
Institutions that held Viracta Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Clear Harbor Asset Management, LLC | 25,000 | $97.0K |
| Schonfeld Strategic Advisors LLC | 10,800 | $42.0K |
| Boothbay Fund Management, LLC | 10,310 | $40.0K |
| New York State Common Retirement Fund | 411 | $2.00K |
| Captrust Financial Advisors | 455 | $2.00K |
| Curi Capital | 245 | $1.00K |
| Spire Wealth Management | 142 | $1.00K |
| Credit Suisse AG | 19 | $0 |